Kala Bio Announces Board and Executive Compensation Changes
Ticker: KALA · Form: 8-K · Filed: Apr 11, 2025 · CIK: 1479419
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
TL;DR
Kala Bio shakes up board & exec pay on April 10th.
AI Summary
Kala Bio, Inc. announced on April 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. These changes are effective as of April 10, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Numbers
- 001-38150 — SEC File Number (Identifies the company's filing history with the SEC.)
- 27-0604595 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- KALA BIO, Inc. (company) — Registrant
- Delaware (company) — State of Incorporation
- Arlington, MA (company) — Principal Executive Offices Location
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of 'certain officers' and 'directors' but does not specify the exact roles in the provided text.
Who are the newly elected directors?
The filing mentions the election of directors but does not name the individuals in the provided text.
What are the key changes in the compensatory arrangements for officers?
The filing notes updates to 'Compensatory Arrangements of Certain Officers' but does not detail the specific changes in the provided text.
What is the effective date of these reported changes?
The earliest event reported is dated April 10, 2025, which is also the date of report.
What is the primary business of Kala Bio, Inc.?
Kala Bio, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding KALA BIO, Inc. (KALA).